NCT06816992 2025-03-20ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLCORIC PharmaceuticalsPhase 1 Recruiting76 enrolled
NCT03965845 2022-09-19A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid TumorsCalithera Biosciences, IncPhase 1/2 Completed53 enrolled